Compugen Ltd. (CGEN) vs Entrada Therapeutics, Inc. (TRDA)

A side-by-side comparison of Compugen Ltd. and Entrada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Compugen Ltd. logo
CGEN
Compugen Ltd.
$210M
$2.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Entrada Therapeutics, Inc. logo
TRDA
Entrada Therapeutics, Inc.
$210M
$5.40HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT

Total return — CGEN vs TRDA

growth of $100 · dividends reinvested · last 5y
CGEN -62.7% (-17.9%/yr)TRDA -77.1% (-25.5%/yr)CGEN compounded faster over this window
050100150Start $10020222023202420252026$37$23
CGEN TRDA

CGEN vs TRDA: by the numbers

  • •CGEN is the larger company ($210M vs $210M market cap).
  • •CGEN is profitable (47.55% net margin) while TRDA runs a net loss (-3537.73%).

Metrics side by side

Valuation

MetricCGENTRDA
P/E ratio5.91N/A
P/S ratio2.8444.75
P/B ratio2.370.90

Profitability

MetricCGENTRDA
Gross margin86.89%83.89%
Operating margin40.94%-613.66%
Net margin47.55%-3537.73%
ROE39.66%-71.02%
ROIC26.14%-63.61%

Growth (annualized)

MetricCGENTRDA
Revenue CAGR (5Y)105.91%N/A
Total return CAGR (5Y)-18.39%N/A

Frequently asked

Is CGEN or TRDA more profitable?
CGEN runs the higher net margin — CGEN at 47.55% versus TRDA at -3537.73%.

Go deeper

Full CGEN analysisFull TRDA analysisInteractive comparison tool

Dig into the metrics

Compugen P/E ratioCompugen ROEEntrada Therapeutics ROECompugen operating marginEntrada Therapeutics operating marginCompugen revenue growthEntrada Therapeutics revenue growthCompugen free cash flowEntrada Therapeutics free cash flow

Compugen & Entrada Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.